Dr. Tyler Paul Johnson, MD

Dr. Johnson practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Johnson's NPI, 1689945362, was assigned on January 26, 2012. Dr. Johnson graduated from Perelman School of Medicine - Philadelphia in 2009. Dr. Johnson holds California license A114397.

Dr. Johnson's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Johnson's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Johnson is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Johnson to 1 more hospital, named with a free account. Dr. Johnson's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Johnson practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Johnson's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Johnson is board certified in medical oncology by the American Board of Internal Medicine. Dr. Johnson is licensed in California.

Dmand AI lists breast cancer, colorectal cancer and lymphoma among the conditions Dr. Johnson treats.

CMS data shows 491 Medicare services from Dr. Johnson across 6 procedure codes in 2024, for 166 Medicare patients. Medicare paid $68,040 for them.

CMS counts 166 Medicare patients who saw Dr. Johnson in 2024. The largest group is 65 to 74, with 78 patients. 74% of them have high blood pressure, and 66% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Johnson's median patient age at 61, with 47% women.

In 2024, Dr. Johnson wrote 108 Medicare Part D claims for 37 patients. 90% of them were for generic drugs. CMS names the drug for 55 of them, across 4 drugs with 11 or more claims each, at $555 in total drug cost. In 2023, CMS named 40 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Johnson for performance year 2024, reported as part of a group. Dr. Johnson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Johnson as offering telehealth.

Dmand AI links 9 papers to Dr. Johnson, published from 2020 to 2025. 2021 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols. Dr. Johnson has published most often in J Clin Oncol. Dr. Johnson's most frequent co-authors are George A. Fisher, MD, Gregory Marshall Heestand, MD and Ranjana Advani, MD.

CMS Open Payments shows 10 general payments to Dr. Johnson from 7 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 74% of the total. Servier Pharmaceuticals LLC paid the most, $2,380.

Dr. Johnson graduated from Perelman School of Medicine - Philadelphia in 2009.

Dr. Johnson is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.